Clustera | Mono-infections | Double infections | Triple infections | |
---|---|---|---|---|
+ III | + IV | + III + IV | ||
Cluster II | 7/56 (12.5%) | 18/56 (32.2%) | 5/56 (8.9%) | 5/56 (8.9%) |
G: 1/7 (14.3% | G: 1/7 (14.3%) | G: 0/7 (0%) | G: 0/7 (0%) | |
A: 2/15 (13.3%) | A: 1/15 (6.7%) | A: 4/15 (26.7%) | A: 1/15 (6.7%) | |
V: 4/34 (11.8%) | V: 16/34 (47.1%) | V: 1/34 (2.9%) | V: 4/34 (11.8%) | |
Cluster III | 7/56 (12.5%) | 6/56 (10.7%) | ||
G: 0/7 (0%) | G: 2/7 (28.6%) | |||
A: 3/15 (20%) | A: 1/15 (6.7%) | |||
V: 4/34 (11.8%) | V: 3/34 (8.8%) | |||
Cluster IV | 8/56 (14.3%) | |||
G: 3/7 (42.8%) | ||||
A: 3/15 (20%) | ||||
V: 2/34 (5.%) | ||||
Total | Mono-infections | Double infections | Mixed infections (double and triple) | |
22/56 (39.3%) | 29/56 (51.8%) | 34/56 (60.7%) | ||
G: 4/7 (57.1%) | G: 3/7 (42.9%) | G: 3/7 (42.9%) | ||
A: 8/15 (53.3%) | A: 6/15 (40%) | A: 7/15 (46.7%) | ||
V: 10/34 (29.4%) | V: 20/34 (58.8%) | V: 24/34 (70.6%) |